« Previous
Next »
Progress in Pediatric Cardiology
Volume 25, Issue 1
, Pages 23-25
, April 2008
Epidemiological and outcomes research in children with pediatric cardiomyopathy: Discussions from the international workshop on primary and idiopathic cardiomyopathies in children
References
- National Institutes of Health-sponsored workshop on inflammation and immunity in dilated cardiomyopathy. Mayo Clin Proc. 2006;81:199–204
- Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol. 2005;23:2629–2636
- . Cardiovascular trials in long-term survivors of childhood cancer. J Clin Oncol. 2004;22:769–773
- Combined prognostic value of peak O(2) uptake and microvolt level T-wave alternans in patients with idiopathic dilated cardiomyopathy. Int J Cardiol. 2007;121:23–29
- The reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function. Circulation. 2001;104:310–316
- Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J. 2000;139:S86–S95
- The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647–1655
- Carvedilol for children and adolescents with heart failure: a randomized clinical trial. JAMA. 2007;298:1214–1216
- . Clinical trials and rare diseases. N Engl J Med. 2003;348:2455–2456
- . Ventricular dysfunction clinical research in infants, children and adolescents. Prog Pediatr Cardiol. 2000;12:1–28
PII: S1058-9813(07)00163-4
doi: 10.1016/j.ppedcard.2007.11.003
© 2007 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Progress in Pediatric Cardiology
Volume 25, Issue 1
, Pages 23-25
, April 2008
